# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
A study finds that GLP-1 treatments, including Novo Nordisk's Ozempic and Eli Lilly's Mounjaro, significantly reduce th...
UK regulators reprimand Novo Nordisk for failing to disclose nearly $10 million in fees and expenses. The PMCPA cites breaches ...
https://news.bloomberglaw.com/health-law-and-business/ozempic-may-lower-risk-of-obesity-related-cancers-study-finds
The S&P 500 and Nasdaq 100 indices surged to new all-time highs on Thursday, as investors heightened their expectations for...
New study suggests a potential link between Novo Nordisk's GLP-1 drugs, Ozempic and Wegovy, and NAION, a condition that can...
https://www.statnews.com/2024/07/03/ozempic-wegovy-naion-vision-loss-study/A new observational study on Wednesday reported for ...
https://nypost.com/2024/07/03/lifestyle/potential-link-between-ozempic-wegovy-and-serious-eye-condition-study/Researchers say t...
American leaders push for lower drug prices, highlighting recent legislation and widespread support for affordable medications....